PHF6 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia

Leuk Res. 2023 Apr:127:107044. doi: 10.1016/j.leukres.2023.107044. Epub 2023 Feb 15.

Affiliations

¹ Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
³ Department of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: ggarciam@mdanderson.org.

PMID: 36801700
DOI: 10.1016/j.leukres.2023.107044

No abstract available

Keywords: AML; CMML; MDS; PHF6.

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Leukemia, Myeloid, Acute* / genetics
Leukemia, Myelomonocytic, Chronic* / genetics
Mutation
Myelodysplastic Syndromes* / genetics
Repressor Proteins / genetics

Substances

PHF6 protein, human
Repressor Proteins